Molecular profiling via next generation sequencing, using the Oncomine Precision Assay (Thermo Fisher Scientific), for a standard lung carcinoma panel found no actionable oncogenic drivers in the Standard Lung carcinoma sub-panel (DNA targets: BRAF, EGFR, KRAS & MET exon 14 skipping; RNA fusions: ALK, ROS1, RET, MET, NTRK1, NTRK2 & NTRK3). The gene discussed is MET; the disease is lung carcinoma.